November 9, 2016
Nicox: update on Latanoprostene bunod and AC-170
Nicox S.A., the international ophthalmic R&D company, has provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: featured
November 8, 2016
BD launches first syringe designed for use with Humulin R U-500 insulin
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
November 8, 2016
After $195 million in talc verdicts, J&J strives to change court
After a $67.5 million jury verdict against Johnson & Johnson…
November 7, 2016
Orphan drugs make 35% Horizon's sale in Q3 2016
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
November 4, 2016
Lartruvo-soft tissue sarcoma drug to sell in U.S.
FDA granted accelerated approval to Lartruvo (olaratumab) injection, in combination with doxorubicin, for the treatment of adult patients…
November 3, 2016
Horizon’s urea cycle disorder drug to sell in Canada
Horizon Pharma has announced that Ravicti (glycerol phenylbutyrate) Oral Liquid is now available in Canada through its affiliate….
November 3, 2016
Alkermes awards $1M to support people affected by mental health
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…
November 3, 2016
LeoPharma and Morphosys join forces to fight skin diseases
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
November 2, 2016
Eli Lilly, Incyte’s rheumatoid arthritis drug studies show positive effect
Eli Lilly and Company and Incyte Corporation have announced on Wednesday that new data from RA-BEACON – a pivotal phase 3 study…
November 2, 2016
Allergan announces $10 B accelerated share repurchase, initiation of cash dividend in 2017
Allergan has completed its initial $5 billion in share repurchases under its previously announced share repurchase program…